|
Adlyfe Promotes Roxanne Duan to President
ROCKVILLE, MARYLAND, April 14, 2009 -- Adlyfe, a private company developing a novel platform for protein folding and amyloid diseases, announced today that they have promoted Roxanne Duan to President. Chief Executive Officer Alan S. Rudolph, "Roxanne has played a key role in leading our progress toward moving our unique platform forward and in our recent success with our partnership program. I look forward to working with her in her new role which will include taking the next step in the development of this technology." Dr. Duan will continue her role in leading the research and development team in the design and validation of additional PronucleonTM ligands for new targets in protein folding events and associated diseases including Alzheimer's and Parkinson's disease.
For More Information
Cindy Miller
Adlyfe Inc.
301-424-8344
cmiller@adlyfe.com
|
